7 Special Dividend Payers Shelling Out Up To 14.6%
Using vanilla websites for your dividend research? Be careful.
DDS - Dillard's, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$557.50
DETAILS
HIGH:
$650.00
LOW:
$465.00
MEDIAN:
$557.50
CONSENSUS:
$557.50
DOWNSIDE:
0.77%
Stock News
3 Reasons Why Growth Investors Shouldn't Overlook Dillard's (DDS)
Dillard's (DDS) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Dillard's Posted a Huge Earnings Beat—So Why Did the Rally Fade?
Dillard's Inc. NYSE: DDS stock surged after the company posted a massive first-quarter earnings beat, but the rally quickly faded as investors realized much of the upside was tied to a litigation settlement. Shares ultimately ended the session only slightly higher, as investors appeared more cautious after digging into the report.
Dillard's: Strength Is Temporary
Dillard's, Inc. reported a clear improvement in sales growth in Q1, also helping margin stability. The improvement is driven by tariff-related apparel inflation instead of DDS's operational strength. DDS's outlook is still weak. E-commerce continues to erode department store traffic, and the consumer sentiment is currently very low.
Dillard's Q1 Earnings & Sales Beat Estimates, Retail Sales Up 3%
DDS tops Q1 estimates as comparable-store sales rise 3%, boosted by merchandise demand and margin gains.
Buy Dillard's (DDS) Stock After Its Massive Q1 Earnings Beat?
Dillard's (DDS) gave a reminder of why it has quietly been one of retail's strongest long-term performers after crushing Q1 earnings expectations on Thursday morning.
Nasdaq Jumps Over 200 Points; Dillard's Shares Gain After Q1 Earnings
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 200 points on Thursday.
Dillard's (DDS) Q1 Earnings and Revenues Surpass Estimates
Dillard's (DDS) came out with quarterly earnings of $16.04 per share, beating the Zacks Consensus Estimate of $10.13 per share. This compares to earnings of $10.39 per share a year ago.
Dillard's, Inc. Reports First Quarter Results
LITTLE ROCK, Ark., May 14, 2026 (GLOBE NEWSWIRE) -- Dillard's, Inc. (NYSE: DDS) (the “Company” or “Dillard's”) announced operating results for the 13 weeks ended May 2, 2026. This release contains certain forward-looking statements. Please refer to the Company's cautionary statements included below under “Forward-Looking Information.”
Dillard's, Inc. to Report First Quarter Results
LITTLE ROCK, Ark., May 13, 2026 (GLOBE NEWSWIRE) -- Dillard's, Inc. (DDS: NYSE) will announce results for the 13 weeks ended May 2, 2026 tomorrow before the open of the New York Stock Exchange.
Abacus FCF Advisors LLC Has $7.12 Million Stock Holdings in Dillard’s, Inc. $DDS
Abacus FCF Advisors LLC grew its holdings in Dillard's, Inc. (NYSE: DDS) by 37.3% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 11,741 shares of the company's stock after acquiring an additional 3,191 shares during the period. Abacus FCF Advisors LLC
Dividend Champion, Contender, And Challenger Highlights: Week Of April 26
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
Dillard’s, Inc. $DDS Shares Sold by Asset Management One Co. Ltd.
Asset Management One Co. Ltd. reduced its stake in shares of Dillard's, Inc. (NYSE: DDS) by 33.5% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,548 shares of the company's stock after selling 1,281 shares during the period. Asset Management One Co.
Dillard's Introduces Cyd Morris x Gianni Bini
A Nostalgic, Limited-Edition Capsule Collection Inspired by Coastal Ease LITTLE ROCK, Ark., April 07, 2026 (GLOBE NEWSWIRE) -- Dillard's, Inc. (“Dillard's”) (NYSE: DDS) is pleased to introduce Cyd Morris x Gianni Bini.
Analysts Set Dillard’s, Inc. (NYSE:DDS) Price Target at $519.67
Dillard's, Inc. (NYSE: DDS - Get Free Report) has earned a consensus recommendation of "Reduce" from the five brokerages that are covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a sell recommendation and three have issued a hold recommendation on the company. The average 12-month target price among analysts that have
Dillard's Introduces Amanda Jones Vaughan x Antonio Melani
LITTLE ROCK, Ark., March 02, 2026 (GLOBE NEWSWIRE) -- Dillard's, Inc. (“Dillard's”) (NYSE: DDS) is pleased to introduce Amanda Jones Vaughan x Antonio Melani.
Dillard's Q4 Earnings Beat Estimates, Comparable Store Sales Down 1%
DDS beats Q4 EPS estimates but misses on revenues as comps slip 1% and shares tumble 8% on weak sales and a cautious demand outlook.
Pre-Market Rebound
Pre-market futures are busy climbing out of the deep hole Monday's market dug for itself, particularly on the blue-chip Dow index. Tariff concerns and possible military conflict with Iran are issues that have not gone away, but neither have they poisoned the well.
Dillard's (DDS) Tops Q4 Earnings Estimates
Dillard's (DDS) came out with quarterly earnings of $10.08 per share, beating the Zacks Consensus Estimate of $9.98 per share. This compares to earnings of $13.48 per share a year ago.
Dillard's, Inc. Reports Fourth Quarter and Fiscal Year Results
LITTLE ROCK, Ark., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Dillard's, Inc. (NYSE: DDS) (the “Company” or “Dillard's”) announced operating results for the 13 and 52 weeks ended January 31, 2026. This release contains certain forward-looking statements. Please refer to the Company's cautionary statements included below under “Forward-Looking Information.”
Price Targets
Dillard's price target raised to $465 from $460 at UBS
$465.00
(was $559.12)
UBS
Dillard's price target lowered to $650 from $700 at Telsey Advisory
$650.00
(was $606.67)
Telsey Advisory
Dillard's Inc. (DDS) PT Raised to $460 at UBS: 'Adept to Drive Modest Sales Growth'
$460.00
(was $669.49)
Mauricio Serna
·
UBS
Dillard's price target lowered to $380 from $475 at Telsey Advisory
$380.00
(was $349.65)
Dana Telsey
·
Telsey Advisory
CFRA Downgrades Dillard's Inc. (DDS) to Hold
$372.00
(was $354.22)
Zachary Warring
·
CFRA
UBS Reiterates Sell Rating on Dillard's Inc. (DDS)
$192.00
(was $434.45)
Mauricio Serna
·
UBS
CFRA Reiterates Buy Rating on Dillard's Inc. (DDS)
$500.00
(was $434.45)
Zachary Warring
·
CFRA